Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 21, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Elevation Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 16
| |||||||
Monte Rosa Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Aclaris Therapeutics, Inc.
| 4.51K |
—
|
—
|
∞
| 4.51K |
Jun 1 - Jun 2
| |||||||
Aclaris Therapeutics, Inc.
| -53.93K |
$17.05 | -$919,589.25 | -11.04% | 434.45K |
Nov 10 - Nov 14
|
Scheduled
| ||||||
Aclaris Therapeutics, Inc.
| -41.17K |
$17.01 | -$700,355.02 | -7.78% | 488.38K |
Oct 24 - Oct 26
|
Scheduled
| ||||||
Aclaris Therapeutics, Inc.
| -52.04K |
$16.57 | -$862,109.13 | -8.95% | 529.55K |
Oct 17 - Oct 18
|
Scheduled
| ||||||
Aclaris Therapeutics, Inc.
| -7.32K |
$16.16 | -$118,349.25 | -1.24% | 581.59K |
Oct 7
|
Scheduled
| ||||||
Aclaris Therapeutics, Inc.
| -45.54K |
$16.45 | -$749,002.06 | -7.18% | 588.92K |
Oct 4 - Oct 6
|
Scheduled
| ||||||
Elevation Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Aclaris Therapeutics, Inc.
| -19.57K |
$15.14 | -$296,268.88 | -100.00% |
0
|
Jun 17
|
Scheduled
| ||||||
Monte Rosa Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Aclaris Therapeutics, Inc.
| 3.36K |
—
|
—
| +20.70% | 19.57K |
Jun 2 - Jun 3
| |||||||
Elevation Oncology, Inc.
| 2.54M |
$16.00 | $3,000,000.00 | +858.33% | 2.83M |
Jun 29
| |||||||
Elevation Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 24
| |||||||
Monte Rosa Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 23
| |||||||
Elevation Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Monte Rosa Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 3
| |||||||
Aclaris Therapeutics, Inc.
| 7.33K |
—
|
—
| +82.62% | 16.21K |
Jun 4 - Jun 6
| |||||||
Aclaris Therapeutics, Inc.
| 8.88K |
—
|
—
|
∞
| 8.88K |
Mar 2
| |||||||
Zosano Pharma Corp
| 689.65K |
$1.45 | $999,999.75 | +34.00% | 2.72M |
Dec 2
| |||||||
Sunesis Pharmaceuticals Inc
| 2.5M |
$0.60 | $1,500,000.00 | +32.89% | 10.1M |
Jul 15
| |||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Zosano Pharma Corp
| 428.57K |
$3.50 | $1,499,998.50 | +26.79% | 2.03M |
Apr 11
| |||||||
Sunesis Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Loxo Oncology, Inc.
| -1.40M |
$179.43 | -$251,202,000.00 | -40.71% | 2.04M |
Jul 10
| |||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 7
| |||||||
Zosano Pharma Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Zosano Pharma Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Loxo Oncology, Inc.
| -250.00K |
$80.50 | -$20,125,000.00 | -6.78% | 3.44M |
Dec 19
| |||||||
Loxo Oncology, Inc.
| -500.00K |
$75.00 | -$37,500,000.00 | -11.94% | 3.69M |
Nov 22
| |||||||
Aclaris Therapeutics, Inc.
| 108.6K |
$23.02 | $2,499,995.02 | +20.65% | 634.46K |
Aug 16
| |||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 9
| |||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Zeltiq Aesthetics Inc
| -1.61M |
—
|
—
| -100.00% |
0
|
Apr 28
| |||||||
Loxo Oncology, Inc.
| 160K |
$31.00 | $4,960,000.00 | +3.97% | 4.19M |
Jan 10
| |||||||
Zeltiq Aesthetics Inc
| -500.00K |
$36.39 | -$18,195,038.45 | -23.84% | 1.6M |
Aug 11
| |||||||
Syros Pharmaceuticals, Inc.
| 908.57K |
$12.50 |
—
|
∞
| 908.57K |
Jul 6
| |||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Zeltiq Aesthetics Inc
| 6.2K |
—
|
—
| +89.35% | 13.14K |
Jun 16
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.